Osteogenic efficacy enhancement of kaempferol through an engineered layer-by-layer matrix: A study in ovariectomized rats

Nanomedicine

Volumn 8, Issue 5, 2013, Pages 757-771

  Gupta, Girish K ^a   Kumar, Avinash ^a   Khedgikar, Vikram ^a   Kushwaha, Priyanka ^a   Gautam, Jyoti ^a   Nagar, Geet K ^a   Gupta, Varsha ^a   Verma, Ashwni ^a   Dwivedi, Anil Kumar ^a   Misra, Amit ^a   Trivedi, Ritu ^a   Mishra, Prabhat Ranjan ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

bone mineralization; controlled release; kaempferol; layer by layer matrix; osteoporosis

Indexed keywords

ALGINIC ACID; CALCIUM CARBONATE; DEOXYCHOLATE SODIUM; FLUORESCEIN ISOTHIOCYANATE; KAEMPFEROL; POLYELECTROLYTE; PROTAMINE SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; BONE MARROW CELL; BONE MINERALIZATION; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; DRUG BIOAVAILABILITY; DRUG FORMULATION; FEMALE; INTESTINE ABSORPTION; LAYER BY LAYER MATRIX; NONHUMAN; OSTEOCYTE; OVARIECTOMY; PH; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; UTERUS WEIGHT; ZETA POTENTIAL;

EID: 84877672348     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.171     Document Type: Article

References (39)

1. Li ZZ, Wen LX, Shao L, Chen JF. Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J. Control. Release 98(2), 245-254 (2004).
2. Kim HW, Knowles JC, Kim HE. Hydroxyapatite/poly (-caprolactone) composite coatings on hydroxyapatite porous bone scaffold for drug delivery. Biomaterials 25(7-8), 1279-1287 (2004).
3. Volodkin DV, Larionova NI, Sukhorukov GB. Protein encapsulation via porous CaCO3 microparticles templating. Biomacromolecules 5(5), 1962-1972 (2004).
4. Volodkin DV, Petrov AI, Prevot M, Sukhorukov GB. Matrix polyelectrolyte microcapsules: new system for macromolecule encapsulation. Langmuir 20(8), 3398-3406 (2004).
5. Caruso F. Nanoengineering of particle surfaces. Adv. Mater. 13(1), 11-22 (2001).
6. Trivedi R, Kumar S, Kumar A et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats. Mol. Cell. Endocrinol. 289(1-2), 85-93 (2008).
7. Arjmandi BH, Birnbaum R, Goyal NV et al. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content. Am. J. Clin. Nutr. 68(Suppl. 6), 1364S-1368S (1998).
8. Pandey R, Gautam AK, Bhargavan B et al. Total extract and standardized fraction from the stem bark of Butea monosperma have osteoprotective action: evidence for the nonestrogenic osteogenic effect of the standardized fraction. Menopause 17(3), 602-610 (2010).
9. Tyagi AM, Gautam AK, Kumar A et al. Medicarpin inhibits osteoclastogenesis and has nonestrogenic bone conserving effect in ovariectomized mice. Mol. Cell. Endocrinol. 325(1-2), 101-109 (2010).
10. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 81(Suppl. 1), 230S-242S (2005).
11. Shukla P, Gupta G, Singodia D et al. Emerging trend in nano-engineered polyelectrolyte-based surrogate carriers for delivery of bioactives. Expert Opin. Drug Deliv. 7(9), 993-1011 (2010).
12. Decher G. Fuzzy nanoassemblies: toward layered polymeric multicomposites. Science 277(5330), 1232-1237 (1997).
13. Dubas ST, Schlenoff JB. Factors controlling the growth of polyelectrolyte multilayers. Macromolecules 32(24), 8153-8160 (1999).
14. Shao Y, Zhu B, Li J, Liu X, Tan X, Yang X. Novel chitosan microsphere-templated microcapsules suitable for spontaneous loading of heparin. Mater. Sci. Eng. C 29(3), 936-941 (2009).
15. Lvov YM, Lu Z, Schenkman JB, Zu X, Rusling JF. Direct electrochemistry of myoglobin and cytochrome P450cam in alternate layer-by-layer films with DNA and other polyions. J. Am. Chem. Soc. 120(17), 4073-4080 (1998).
16. Dimitrova M, Affolter C, Meyer F et al. Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films. Proc. Natl Acad. Sci. USA 105(42), 16320-16325 (2008).
17. Ochs CJ, Such GK, Stadler B, Caruso F. Low-fouling, biofunctionalized, and biodegradable click capsules. Biomacromolecules 9(12), 3389-3396 (2008).
18. Zou Y, Brooks JL, Talwalkar V, Milbrandt TA, Puleo DA. Development of an injectable two-phase drug delivery system for sequential release of antiresorptive and osteogenic drugs. J. Biomed. Mater. Res. B Appl. Biomater. 100(1), 155-162 (2012).
19. Meng J, Hu L. Positively-charged microemulsion for improving the oral bioavailability of alendronate: in-vitro and in-vivo assessment. J. Pharm. Pharmacol. 63(3), 400-408 (2011).
20. Katsumi H, Kusamori K, Sakane T, Yamamoto A. Development of delivery system of bisphosphonates for the treatment of osteoporosis. Yakugaku Zasshi 130(9), 1129-1133 (2010).
21. Cattalini JP, Boccaccini AR, Lucangioli S, Mourino VS. Bisphosphonate-based strategies for bone tissue engineering and orthopaedic implants. Tissue Eng. Part B Rev. 18(5), 323-340 (2012).
22. Gupta GK, Jain V, Mishra PR. Templated ultrathin polyelectrolyte microreservoir for delivery of bovine serum albumin: fabrication and performance evaluation. AAPS PharmSciTech. 12(1), 344-353 (2011).
23. Gupta GK, Gupta VK, Shukla P, Pant AB, Mishra PR. Investigations on cellular interaction of polyelectrolyte based nano-walled reservoir using MCF-7 cell lines: a novel chemotherapeutic approach. J. Pharm. Pharmacol. 61(12), 1601-1607 (2009).
24. Gupta GK, Kansal S, Misra P, Dube A, Mishra PR. Uptake of biodegradable gel-assisted LBL nanomatrix by Leishmania donovani-infected macrophages. AAPS Pharm. Sci. Tech. 10(4), 1343-1347 (2009).
25. Mishra PR, Al Shaal L, Muller RH, Keck CM. Production and characterization of Hesperetin nanosuspensions for dermal delivery. Int. J. Pharm. 371(1-2), 182-189 (2009).
26. He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 31(13), 3657-3666 (2010).
27. Pastoureau P, Chomel A, Bonnet J. Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis. Osteoporos. Int. 5(3), 143-149 (1995).
28. Mosekilde L, Weisbrode SE, Safron JA et al. Evaluation of the skeletal effects of combined mild dietary calcium restriction and ovariectomy in sinclair S-1 minipigs: a pilot study. J. Bone Miner. Res. 8(11), 1311-1321 (1993).
29. Maniatopoulos C, Sodek J, Melcher A. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res. 254(2), 317-330 (1988).
30. Burr DB, Hooser M. Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo. Bone 17(4), 431-433 (1995).
31. Dai RC, Liao EY, Yang C, Wu XP, Jiang Y. Microcracks: an alternative index for evaluating bone biomechanical quality. J. Bone Miner. Metab. 22(3), 215-223 (2004).
32. Girotra M, Rubin MR, Bilezikian JP. The use of parathyroid hormone in the treatment of osteoporosis. Rev. Endocr. Metabolic Disord. 7(1), 113-121 (2006).
33. Hodsman AB, Bauer DC, Dempster DW et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use. Endocr. Rev. 26(5), 688-703 (2005).
34. Shenoy DB, Antipov AA, Sukhorukov GB, Möhwald H. Layer-by-layer engineering of biocompatible, decomposable core-shell structures. Biomacromolecules 4(2), 265-272 (2003).
35. Zhou D, Bruckbauer A, Batchelor M, Kang DJ, Abell C, Klenerman D. Influence of the foundation layer on the layer-by-layer assembly of poly-l-lysine and poly (styrenesulfonate) and its usage in the fabrication of 3D microscale features. Langmuir 20(21), 9089-9094 (2004).
36. Lucas-Abellan C, Fortea I, Gabaldon JA, Nunez-Delicado E. Encapsulation of quercetin and myricetin in cyclodextrins at acidic pH. J. Agric. Food Chem. 56(1), 255-259 (2008).
37. Yamamoto A, Uchiyama T, Nishikawa R, Fujita T, Muranishi S. Effectiveness and toxicity screening of various absorption enhancers in the rat small intestine: effects of absorption enhancers on the intestinal absorption of phenol red and the release of protein and phospholipids from the intestinal membrane. J. Pharm. Pharmacol. 48(12), 1285-1289 (1996).
38. Tomkinson A, Gevers EF, Wit JM, Reeve J, Noble BS. The role of estrogen in the control of rat osteocyte apoptosis. J. Bone Miner. Res. 13(8), 1243-1250 (1998).
39. Sikjaer T, Rejnmark L, Rolighed L, Heickendorff L, Mosekilde L. The effect of adding PTH (1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study. J. Bone Miner. Res. 26(10), 2358-2370 (2011).